MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$16,007K
EPS
-$2.84
Unit: Thousand (K) dollars

Income Statement
2026-06-30
Research and development
9,180
General and administrative expenses
9,205
Acquired in-process research and development
0
Total operating expenses
18,385
Loss from operations
-18,385
Interest income, net
2,258
Other income (expense), net
120
Net loss
-16,007
Basic EPS
-2.84
Diluted EPS
-2.84
Basic Average Shares
5,643,222
Diluted Average Shares
5,643,222
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$16,007K Interest income, net$2,258K Other income(expense), net$120K Loss from operations-$18,385K Total operatingexpenses$18,385K General andadministrative expenses$9,205K Research and development$9,180K

Faeth Therapeutics, Inc. (FTH)

Faeth Therapeutics, Inc. (FTH)